Advertisement

Topics

Update on Strategies to Improve Treatment for Triple Negative Breast Cancer

09:59 EDT 2 Oct 2018 | Cancer Connect

Checkpoint PD-1 inhibitors and Sacituzumab Govitecan (IMMU-132) promising treatment for triple negative breast cancer

Original Article: Update on Strategies to Improve Treatment for Triple Negative Breast Cancer

NEXT ARTICLE

More From BioPortfolio on "Update on Strategies to Improve Treatment for Triple Negative Breast Cancer"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topic

Cancer
  Bladder Cancer Brain Cancer Breast Cancer Cancer Cervical Cancer Colorectal Head & Neck Cancers Hodgkin Lymphoma Leukemia Lung Cancer Melanoma Myeloma Ovarian Cancer Pancreatic Cancer ...